← Browse by Condition
Medical Condition
lung neuroendocrine neoplasm
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT04665739 Phase 2
Recruiting
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Enrollment
70 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT04893785 Phase 2
Recruiting
A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)
Enrollment
35 pts
Location
Italy
Sponsor
National Cancer Institute, Nap...